|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.230 USD | +13.40% |
|
+14.02% | +25.52% |
| 07-14 | Ironwood Pharmaceuticals, Inc. Announces Management Changes | CI |
| 05-27 | Ironwood Says US FDA Approves Linzess Use in Children Aged Two Years and Older With Functional Constipation | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Specialty & Advanced Pharmaceuticals | +13.40% | +14.02% | +25.52% | +448.35% | -68.12% | 696M |  | |  |
- Stock Market
- Stocks
- IRWD Stock
- Charts Ironwood Pharmaceuticals, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
